HOME >> MEDICINE >> NEWS
UCLA scientists identify genetic link to migraine

UCLA geneticists have discovered the first evidence that migraine with aura is a hereditary condition. Reported in the March 1 edition of the American Journal of Human Genetics, the findings will enable researchers to isolate the gene that predisposes people to the painful disorder.

For the first time, we have proof of an isolated genetic link to migraine, said Dr. Aarno Palotie, principal investigator and UCLA professor of pathology and human genetics. This finding moves us one step closer to isolating the gene that predisposes people to migraine headaches with auras.

Paloties team analyzed genetic markers in blood samples from 50 Finnish families with three or more multigenerational members who suffer from the disorder.

In 30 percent of the 430 people studied, Palotie and his colleagues discovered three common markers consistently linked to the q23 region of chromosome 4. No other chromosomal site demonstrated such a strong linkage.

Now that we have narrowed the hunting ground, these findings provide us with a focused direction for identification of the gene itself, Palotie said. They also pave the way for clinical trials of more effective prophylactic drugs.

Migraines affect roughly 12 percent of the population. The headaches are characterized by intense pulsating pain on one side of the head, often with pain behind one eye, nausea, vomiting, and sensitivity to light and noise. Some migraines are preceded by an aura neurological symptoms revealed by visual disturbances up to one hour before the headache begins.


'"/>

Contact: Elaine Schmidt
elaines@support.ucla.edu
310-794-2272
University of California - Los Angeles
25-Feb-2002


Page: 1

Related medicine news :

1. OHSU scientists test medication to treat involuntary weight loss
2. Earlier use of prostate cancer vaccines urged by Hopkins scientists
3. Tobacco industry pays scientists to challenge secondhand smokes link to infant death risk
4. Schepens scientists regenerate optic nerve for the first time
5. OHSU scientists develop MRI approach to improve breast cancer detection
6. UCLA neuroscientists pinpoint new function for mirror neurons
7. Jefferson scientists uncover potential trigger of diabetic kidney disease
8. Johns Hopkins scientists receive presidential medals
9. UCLA brain scientists crack mystery of how alcohol causes intoxication
10. Wisconsin scientists grow critical nerve cells
11. Jefferson scientists help explain statins effects in Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCLA scientists identify genetic link migraine

(Date:8/22/2014)... intensive effort to sterilize feral cats reduced the number of ... a new study reveals. "We investigated whether we ever ... control," Dr. Julie Levy, a professor of shelter medicine at ... a university news release. "Neutering a few cats ... "so we wanted to pick a focused area and throw ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 A national leader ... into new offices with room to grow. , Headquarters for ... to a 60,000-square-foot office building at 8516 N.W. Expressway in ... named one of the Oklahoma’s best places to work by ... The company has hired 120 in the past two years, ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Home ... of in-home care for seniors, is proud to announce ... Series. The upcoming webinar will feature Dr. Suzanne Steinbaum, ... Lenox Hill Hospital in New York City, National Spokesperson ... author. The webinar will cover the issues surrounding women ...
(Date:8/22/2014)... (HealthDay News) -- Inner city children have a higher-than-normal risk ... followed 516 inner city children in four U.S. cities -- ... until age 5 and found that at least 10 percent ... Because only the three most common types of food ... inner city youngsters with food allergies may be even higher, ...
(Date:8/22/2014)... severe disabilities and multiple chronic conditions are screened for ... or no chronic conditions, a new study has found. ... with moderate disabilities or women with only one chronic ... with the Li Ka Shing Knowledge Institute of St. ... often have other measures of social vulnerability, such as ...
Breaking Medicine News(10 mins):Health News:Neutering Project Curbed Feral Cat Population 2Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Food Allergies More Common Among Inner City Kids, Study Finds 2Health News:Women with severe, chronic health issues are screened for breast cancer less often 2
(Date:8/21/2014)... DEERFIELD, Ill. , Aug. 21, 2014 /PRNewswire/ ... reports Baxter International Inc. today announced positive results ... BAX 855, an investigational, extended half-life recombinant factor ... ADVATE [Antihemophilic Factor (Recombinant)], which met its primary ... the prophylaxis arm compared to the on-demand arm. ...
(Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe customer ... , Managing Partner and Healthcare Industry Group Leader, has ... which recognizes the most inspiring people in the life-sciences ... in research and development, marketing, technology, creativity, strategy and ... 2006 as a partner in its leading Rosetta Consulting ...
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Shannon Hartley Shines in PharmaVOICE 100 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
Cached News: